A 5-year observational study of patients with treatment-resistant depression treated with vagus nerve stimulation or treatment as usual: comparison of response, remission, and suicidality, Am. J. Psychiatry, vol.174, pp.640-648, 2017. ,
T3 augmentation of SSRI resistant depression, J. Affect. Disord, vol.91, pp.211-215, 2006. ,
Algorithm-based treatment of major depression in an outpatient clinic: clinical correlates of response to a specific serotonin reuptake inhibitor and to triiodothyronine augmentation, Int. J. Neuropsychopharmacol, vol.6, 2003. ,
Oral ketamine in treatment-resistant depression, J. Clin. Psychopharmacol, vol.37, pp.464-467, 2017. ,
The impact of posttraumatic stress disorder on the 6-Month outcomes in collaborative care management for depression, J. Prim. Care Community Health, vol.7, pp.159-164, 2016. ,
Depression subtypes in predicting antidepressant response: a report from the iSPOT-D trial, Am. J. Psychiatry, vol.172, pp.743-750, 2015. ,
Triiodothyronine augmentation in the treatment of refractory depression, Arch. Gen. Psychiatry, vol.53, 1996. ,
Handbook of Clinical Rating Scales and Assessment in Psychiatry and Mental Health, LLC), 2010. ,
Two-year outcome of vagus nerve stimulation in treatment-resistant depression, J. Clin. Psychopharmacol, vol.30, pp.273-281, 2010. ,
Escitalopram and paroxetine in the treatment of generalised anxiety disorder, Br. J. Psychiatry, vol.189, pp.264-272, 2006. ,
Socio-demographic and clinical predictors of treatment resistant depression: a prospective European multicenter study, J. Affect. Disord, vol.189, pp.224-232, 2016. ,
Extended-release quetiapine fumarate (quetiapine XR): a once-daily monotherapy effective in generalized anxiety disorder. Data from a randomized, double-blind, placebo-and active-controlled study, Int. J. Neuropsychopharmacol, vol.13, p.305, 2010. ,
Lithium's emerging role in the treatment of refractory major depressive episodes: augmentation of antidepressants, Neuropsychobiology, vol.62, pp.36-42, 2010. ,
A randomised, placebo-controlled 24-week study evaluating adjunctive brexpiprazole in patients with major depressive disorder, Acta Neuropsychiatr, vol.31, pp.27-35, 2019. ,
World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of unipolar depressive disorders, part 1: update 2013 on the acute and continuation treatment of unipolar depressive disorders, World J. Biol. Psychiatry, vol.14, pp.334-385, 2013. ,
What is the meaning of treatment resistant/refractory major depression (TRD)? A systematic review of current randomized trials, Eur. Neuropsychopharmacol, vol.17, pp.696-707, 2007. ,
Clinical utility of transcranial direct current stimulation (tDCS) for treating major depression: a systematic review and meta-analysis of randomized, double-blind and sham-controlled trials, J. Psychiatr. Res, vol.47, pp.1-7, 2013. ,
A patient-level meta-analysis of studies evaluating vagus nerve stimulation therapy for treatment-resistant depression, Med. Devices Evid. Res, vol.6, pp.17-35, 2013. ,
Switching medication products during the treatment of psychiatric illness, Int. J. Psychiatry Clin. Pract, vol.23, pp.2-13, 2019. ,
Combination of antidepressant medications from treatment initiation for major depressive disorder: a double-blind randomized study, Am. J. Psychiatry, vol.167, pp.281-288, 2010. ,
Overcoming treatment resistance in chronic depression: a pilot study on outcome and feasibility of the cognitive behavioral analysis system of psychotherapy as an inpatient treatment program, Psychother. Psychosom, vol.84, pp.51-56, 2015. ,
Current and common definitions of treatment-resistant depression: findings from a systematic review and qualitative interviews, Can. J. Psychiatry, vol.64, pp.380-387, 2019. ,
Transcranial direct current stimulation for acute major depressive episodes: meta-analysis of individual patient data, Br. J. Psychiatry, vol.208, pp.522-531, 2016. ,
Comparative efficacy and acceptability of electroconvulsive therapy versus repetitive transcranial magnetic stimulation for major depression: a systematic review and multiple-treatments meta-analysis, Behav. Brain Res, vol.320, pp.30-36, 2017. ,
Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 2008 British Association for Psychopharmacology guidelines, J. Psychopharmacol, 2015. ,
If at first you don't succeed: a review of the evidence for antidepressant augmentation, combination and switching strategies, Drugs, vol.71, pp.43-64, 2011. ,
Presence of individual (residual) symptoms during depressive episodes and periods of remission: a 3-year prospective study, Psychol. Med, vol.41, pp.1165-1174, 2011. ,
, Journal of Affective Disorders, vol.267, pp.264-282, 2020.
Toward an evidence-based, operational definition of treatment-resistant depression: when enough is enough, JAMA Psychiatry, vol.74, pp.9-10, 2017. ,
Efficacy and safety of triiodothyronine supplementation in patients with major depressive disorder treated with specific serotonin reuptake inhibitors, Int. J. Neuropsychopharmacol, vol.11, pp.685-699, 2008. ,
Acceleration and augmentation of antidepressants with lithium for depressive disorders: two meta-analyses of randomized, placebo-controlled trials, J. Clin. Psychiatry, vol.68, pp.935-940, 2007. ,
Cognitive behavioural therapy for insomnia (CBT-I) to treat depression: a systematic review, J. Psychosom. Res, vol.106, pp.1-12, 2018. ,
A randomized, double-blind, placebo-controlled trial of pramipexole augmentation in treatment-resistant major depressive disorder, J. Clin. Psychiatry, vol.74, pp.636-641, 2013. ,
Efficacy of esketamine nasal spray plus oral antidepressant treatment for relapse prevention in patients with treatment-resistant depression: a randomized clinical trial, JAMA Psychiatry, vol.8560, pp.1-11, 2019. ,
Socio-demographic and clinical predictors of non-response/non-remission in treatment resistant depressed patients: a systematic review, Psychiatry Res, vol.240, pp.421-430, 2016. ,
What is important in being cured from: does discordance between physicians and patients matter? (2), J. Affect. Disord, vol.174, pp.372-377, 2015. ,
Duloxetine, 60 mg once daily, for major depressive disorder: a randomized double-blind placebocontrolled trial, J. Clin. Psychiatry, vol.63, pp.308-315, 2002. ,
The adverse effects of comorbid pain on depression outcomes in primary care patients: results from the artist trial, Pain Med, vol.11, pp.732-741, 2010. ,
Major depression and the degree of suicidality: results of the European Group for the Study of Resistant Depression (GSRD), Int. J. Neuropsychopharmacol, vol.21, pp.539-549, 2018. ,
Repeated oral ketamine for out-patient treatment of resistant depression: randomised, double-blind, placebocontrolled, proof-of-concept study, Br. J. Psychiatry, vol.214, pp.20-26, 2019. ,
Risk factors of treatment resistance in major depression: association with bipolarity, J. Affect. Disord, vol.126, pp.268-271, 2010. ,
Diagnosis and definition of treatment-resistant depression, Biol. Psychiatry, vol.53, pp.649-659, 2003. ,
Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD), Mol. Psychiatry, 2018. ,
Relapse in patients on long-term fluoxetine treatment: response to increased fluoxetine dose, J. Clin. Psychiatry, vol.56, pp.52-55, 1995. ,
Difference in treatment outcome in outpatients with anxious versus nonanxious depression: a STAR*D report, Am. J. Psychiatry, vol.165, pp.342-351, 2008. ,
Modafinil augmentation of selective serotonin reuptake inhibitor therapy in mdd partial responders with persistent fatigue and sleepiness, Ann. Clin. Psychiatry, vol.19, pp.153-159, 2007. ,
Clinical experience with high-dosage pramipexole in patients with treatment-resistant depressive episodes in unipolar and bipolar depression, Am. J. Psychiatry, vol.173, pp.107-111, 2016. ,
Standardisation framework for the maudsley staging method for treatment resistance in depression, BMC Psychiatry, vol.18, 2018. ,
A pilot study of the comparative efficacy of 100 Hz magnetic seizure therapy and electroconvulsive therapy in persistent depression, Depress. Anxiety, vol.35, pp.393-401, 2018. ,
Ketamine administration in depressive disorders: a systematic review and meta-analysis, Psychopharmacology (Berl), vol.231, pp.3663-3676, 2014. ,
Dose-response efficacy of paroxetine in preventing depressive recurrences: a randomized, doubleblind study, J. Clin. Psychiatry, vol.59, pp.229-232, 1998. ,
The impact of individual depressive symptoms on impairment of psychosocial functioning, PLoS ONE, vol.9, 2014. ,
Comorbid hypertension in patients with major depressive disorder -Results from a European multicenter study, Eur. Neuropsychopharmacol, vol.29, pp.777-785, 2019. ,
Endocrine disorders. Psychosocial Treatment for Medical Conditions. Routledge, pp.215-244, 2004. ,
Repetitive transcranial magnetic stimulation for treatment-resistant depression: a systematic review and meta-analysis, J. Clin. Psychiatry, vol.75, pp.477-489, 2014. ,
Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990-2015: a systematic analysis for the global burden of disease study, AHRQ Technology Assessments. Agency for Healthcare Research and Quality, vol.388, issue.16, p.31460, 2015. ,
Sertraline treatment of major depression in patients with acute MI or unstable angina, JAMA, vol.288, pp.701-709, 2002. ,
Evidence-based guidelines for treating bipolar disorder: revised third edition recommendations from the British Association for Psychopharmacology, J. Psychopharmacol, vol.30, pp.495-553, 2016. ,
Modafinil augmentation therapy in unipolar and bipolar depression, J. Clin. Psychiatry, vol.74, pp.1101-1107, 2013. ,
The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: acute and long-term treatment of mixed states in bipolar disorder, Members of the WFSBP Task Force on Bipolar Affective Disorders Working on this topic, vol.19, pp.2-58, 2018. ,
URL : https://hal.archives-ouvertes.fr/hal-01791676
Measurement-Based care versus standard care for major depression: a randomized controlled trial with blind raters, Am. J. Psychiatry, vol.172, pp.1004-1013, 2015. ,
, Repetitive transcranial magnetic stimulation for treatmentresistant depression: a systematic review and meta-analysis of randomized controlled trials, Ont. Health Technol. Assess. Ser, vol.16, pp.1-66, 2016.
Impact of comorbid panic and posttraumatic stress disorder on outcomes of collaborative care for late-life depression in primary care, Am. J. Geriatr. Psychiatry, vol.13, pp.48-58, 2005. ,
Antidepressant pharmacotherapy failure and response to subsequent electroconvulsive therapy, J. Clin. Psychopharmacol, vol.30, pp.616-619, 2010. ,
A call for clear and consistent communications regarding the role of pharmacogenetics in antidepressant pharmacotherapy, Clin. Pharmacol. Ther, 2019. ,
Efficacy and safety of flexibly dosed brexpiprazole for the adjunctive treatment of major depressive disorder: a randomized, active-referenced, placebo-controlled study, Curr. Med. Res. Opin, vol.34, pp.633-642, 2018. ,
Multicenter double-blind comparison of sertraline and desipramine for concurrent obsessive-compulsive and major depressive disorders, Arch. Gen. Psychiatry, vol.57, pp.76-82, 2000. ,
Thyroid dysfunction in refractory depression: implications for pathophysiology and treatment, J. Clin. Psychiatry, vol.54, pp.47-54, 1993. ,
Concurrent anxiety and substance use disorders among outpatients with major depression: clinical features and effect on treatment outcome, Drug Alcohol Depend, vol.99, pp.248-260, 2009. ,
An open study of triiodothyronine augmentation of selective serotonin reuptake inhibitors in treatment-resistant major depressive disorder, J. Clin. Psychiatry, vol.66, pp.1038-1042, 2005. ,
Quality of life in major depressive disorder before/after multiple steps of treatment and one-year follow-up, Acta Psychiatr. Scand, vol.131, pp.51-60, 2015. ,
Factors associated with relapse after a response to electroconvulsive therapy in unipolar versus bipolar depression, J. Affect. Disord, vol.208, pp.113-119, 2017. ,
Epidemiology of psychotic depression -systematic review and meta-analysis, Psychol. Med, vol.48, pp.905-918, 2018. ,
Relapse following successful electroconvulsive therapy for major depression: a meta-analysis, Neuropsychopharmacology, vol.38, pp.2467-2474, 2013. ,
Lithium and triiodothyronine augmentation of antidepressants, Can. J. Psychiatry, vol.51, pp.791-793, 2006. ,
Major depressive disorder: a prospective study of residual subthreshold depressive symptoms as predictor of rapid relapse, J. Affect. Disord, vol.50, pp.97-108, 1998. ,
Modafinil improves episodic memory and working memory cognition in patients with remitted depression: a double-blind, randomized, placebo-controlled study, Biol. Psychiatry Cogn. Neurosci. Neuroimaging, vol.2, pp.115-122, 2017. ,
A new prediction model for evaluating treatment-resistant depression, J. Clin. Psychiatry, vol.78, pp.215-222, 2017. ,
Refining prediction in treatment-resistant depression, J. Clin. Psychiatry, vol.79, 2018. ,
Antidepressant effects, of magnetic seizure therapy and electroconvulsive therapy, in treatment-resistant depression, J. Psychiatr. Res, vol.45, pp.569-576, 2011. ,
Double depression": two-year follow-up, Am. J. Psychiatry, vol.140, pp.689-694, 1983. ,
Residual symptoms at remission from depression: impact on long-term outcome, J. Affect. Disord, vol.80, issue.03, pp.54-59, 2004. ,
Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 clinical guidelines for the management of adults with major depressive disorder: section 3. Pharmacological treatments, Can. J. Psychiatry, vol.61, pp.540-560, 2016. ,
Combining mirtazapine with SSRIs or SNRIs for treatment-resistant depression: the MIR RCT, Health Technol. Assess, p.22, 2018. ,
,
A systematic review and meta-analysis of deep brain stimulation for depression, Depress. Anxiety, vol.35, pp.468-480, 2018. ,
Cognitive behavioral analysis system of psychotherapy and brief supportive psychotherapy for augmentation of antidepressant nonresponse in chronic depression: the REVAMP trial, Arch. Gen. Psychiatry, vol.66, pp.1178-1188, 2009. ,
Clinical features of treatment-resistant depression, J. Clin. Psychiatry, vol.62, pp.18-25, 2001. ,
Prognosis and improved outcomes in major depression: a review, Transl. Psychiatry, vol.9, 2019. ,
Optimism and pessimism as predictors of work disability with a diagnosis of depression: a prospective cohort study of onset and recovery, J. Affect. Disord, vol.130, pp.294-299, 2011. ,
Durability of symptomatic responses obtained with adjunctive vagus nerve stimulation in treatment-resistant depression, Neuropsychiatr. Dis. Treat, vol.15, pp.457-468, 2019. ,
British Society for Rheumatology and British Health Professionals in Rheumatology guideline for the management, 2009. ,
, Rheumatology (Oxford), vol.48, pp.436-439
A randomized, placebo-controlled, active-reference, double-blind, flexible-dose study of the efficacy of vortioxetine on cognitive function in major depressive disorder, Neuropsychopharmacology, vol.40, pp.2025-2037, 2015. ,
Treatment-resistant depression: problematic illness or a problem in our approach?, Br. J. Psychiatry, vol.214, pp.1-3, 2019. ,
, Depression. Lancet, vol.392, issue.18, pp.31948-31950, 2018.
Multiple-therapy-resistant major depressive disorder: a clinically important concept, Br. J. Psychiatry, vol.212, pp.274-278, 2018. ,
Comparison of DSM-III-R chronic major depression and major depression superimposed on dysthymia (double depression): validity of the distinction, J. Abnorm. Psychol, vol.109, pp.419-427, 2000. ,
Safety and efficacy of adjunctive second-generation antidepressant therapy with a mood stabiliser or an atypical antipsychotic in acute bipolar depression: a systematic review and meta-analysis of randomised placebo-controlled trials, Lancet Psychiatry, vol.3, pp.1138-1146, 2016. ,
Anhedonia predicts poorer recovery among youth with selective serotonin reuptake inhibitor treatment-resistant depression, J. Am. Acad. Child Adolesc. Psychiatry, vol.51, pp.404-411, 2012. ,
Transcranial direct current stimulation (tDCS) in the treatment of depression: systematic review and meta-analysis of efficacy and tolerability, Neurosci. Biobehav. Rev, vol.57, pp.46-62, 2015. ,
Canadian network for mood and anxiety treatments (CANMAT) 2016 clinical guidelines for the management of adults with major depressive disorder: section 4. Neurostimulation treatments, Can. J. Psychiatry, vol.61, pp.561-575, 2016. ,
Efficacy and safety of pregabalin in the treatment of generalized anxiety disorder: a 6-week, multicenter, randomized, double-blind, placebo-controlled comparison of pregabalin and venlafaxine, J. Clin. Psychiatry, vol.67, pp.771-782, 2006. ,
Aerobic exercise for adult patients with major depressive disorder in mental health services: a systematic review and meta-analysis, Depress. Anxiety, vol.36, pp.39-53, 2019. ,
Childhood maltreatment and characteristics of adult depression: meta-analysis, Br. J. Psychiatry, vol.210, pp.96-104, 2017. ,
Treatment of antidepressant nonresponders: augmentation or switch?, J. Clin. Psychiatry, vol.59, pp.35-41, 1998. ,
A systematic review and meta-analysis of lithium augmentation of tricyclic and second generation antidepressants in major depression, J. Affect. Disord, vol.168, pp.269-275, 2014. ,
Atypical antipsychotic augmentation in major depressive disorder: a meta-analysis of placebo-controlled randomized trials, Am. J. Psychiatry, vol.166, pp.980-991, 2009. ,
A comparison of lithium and T 3 augmentation following two failed medication treatments for depression: a STAR*D report, Am. J. Psychiatry, vol.163, pp.1519-1530, 2006. ,
,
The International Society for Bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders, Am. J. Psychiatry, vol.170, pp.1249-1262, 2013. ,
Efficacy and safety of selegiline transdermal system (STS) for the atypical subtype of major depressive disorder: pooled analysis of 5 short-term, placebo-controlled trials, CNS Spectr, vol.19, pp.324-329, 2014. ,
Managing partial response or nonresponse, J. Clin. Psychiatry, vol.70, pp.16-25, 2009. ,
Ziprasidone augmentation of escitalopram for major depressive disorder: efficacy results from a randomized, double-blind, placebo-controlled study, Am. J. Psychiatry, vol.172, pp.1251-1258, 2015. ,
S -Adenosyl Methionine (SAMe) augmentation of serotonin reuptake inhibitors for antidepressant nonresponders with major depressive disorder: a double-blind, randomized clinical trial, Am. J. Psychiatry, vol.167, pp.942-948, 2010. ,
Psychiatric comorbidity as a predictor of clinical response to nortriptyline in treatment-resistant major depressive disorder, J. Clin. Psychiatry, vol.64, pp.1357-1361, 2003. ,
Augmentation of antidepressants with atypical antipsychotic medications for treatment-resistant major depressive disorder: a meta-analysis, J. Clin. Psychiatry, vol.68, pp.826-831, 2007. ,
Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 clinical guidelines for the management of adults with major depressive disorder: section 2. Psychological treatments, Can. J. Psychiatry, vol.61, pp.524-539, 2016. ,
A systematic metareview of predictors of antidepressant treatment outcome in major depressive disorder, J. Affect. Disord, vol.243, pp.503-515, 2019. ,
Patterns of response to antidepressants in major depressive disorder: drug resistance or worsening of depression are associated with a bipolar diathesis, Eur. Neuropsychopharmacol, vol.29, pp.825-834, 2019. ,
Single, repeated, and maintenance ketamine infusions for treatment-resistant depression: a randomized controlled trial, Am. J. Psychiatry, vol.176, pp.401-409, 2019. ,
Efficacy and safety of flexibly dosed esketamine nasal spray combined with a newly initiated oral antidepressant in treatment-resistant depression: a randomized double-blind active-controlled study, Am. J. Psychiatry, vol.176, pp.428-438, 2019. ,
The three-year naturalistic course of major depressive disorder, dysthymic disorder and double depression, J. Affect. Disord, vol.115, pp.450-459, 2009. ,
Social and occupational functioning impairment in patients in partial versus complete remission of a major depressive disorder episode. A six-month prospective epidemiological study, Eur. Psychiatry, vol.25, pp.58-65, 2010. ,
Validity and reliability of the Functioning Assessment Short Test (FAST) in bipolar disorder, Clin. Pract. Epidemiol. Ment. Heal, vol.3, 2007. ,
Oral ketamine for depression, J. Clin. Psychiatry, vol.80, 2019. ,
Personality and outcome in individuals with treatment-resistant depression-Exploring differential treatment effects in the Tavistock Adult Depression Study (TADS), J. Consult. Clin. Psychol, vol.87, pp.433-445, 2019. ,
Staging methods for treatment resistant depression. A systematic review, J. Affect. Disord, vol.137, pp.35-45, 2012. ,
Difficult-to-treat depression: a clinical and research roadmap for when remission is elusive, Aust. N. Z. J. Psychiatry, vol.53, pp.109-118, 2019. ,
Effects of 12 months of vagus nerve stimulation in treatment-resistant depression: a naturalistic study, Biol. Psychiatry, vol.58, pp.355-363, 2005. ,
Improving depression outcome by patient-centered medical management, Am. J. Psychiatry, vol.175, pp.1187-1198, 2018. ,
Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report, Am. J. Psychiatry, vol.163, pp.1905-1917, 1905. ,
Selecting among second-step antidepressant medication monotherapies: predictive value of clinical, demographic, or first-step treatment features, Arch. Gen. Psychiatry, vol.65, pp.870-880, 2008. ,
Treatment of neurocognitive symptoms in unipolar depression: a systematic review and future perspectives, J. Affect. Disord, vol.221, pp.205-221, 2017. ,
Chronic depression, Arch. Gen. Psychiatry, vol.62, 2005. ,
Vagus nerve stimulation for depression: efficacy and safety in a European study, Psychol. Med, vol.38, pp.651-661, 2008. ,
The role of ketamine in treatment-resistant depression: a systematic review, Curr. Neuropharmacol, vol.12, pp.444-461, 2014. ,
A closer look at treatment resistant depression: is it due to a bipolar diathesis?, J. Affect. Disord, vol.84, pp.251-257, 2005. ,
Assessing treatment effects in clinical trials with the Discan metric of the Sheehan Disability Scale, Int. Clin. Psychopharmacol, vol.23, pp.70-83, 2008. ,
Transcranial direct current stimulation for major depression: an updated systematic review and meta-analysis, Int. J. Neuropsychopharmacol, vol.17, pp.1443-1452, 2014. ,
An update on antidepressant use in bipolar depression, Curr. Psychiatry Rep, vol.14, pp.696-704, 2012. ,
A double-blind, randomized, placebo-controlled, dose-frequency study of intravenous ketamine in patients with treatmentresistant depression, Am. J. Psychiatry, vol.173, pp.816-826, 2016. ,
Clinical factors associated with treatment resistance in major depressive disorder: results from a European multicenter study, J. Clin. Psychiatry, vol.68, pp.1062-1070, 2007. ,
Adjunctive atypical antipsychotic treatment for major depressive disorder: a metaanalysis of depression, quality of life, and safety outcomes, PLoS Med, vol.10, 2013. ,
Personality traits as risk factors for treatment-resistant depression, PLoS ONE, vol.8, 2013. ,
Low openness on the revised NEO personality inventory as a risk factor for treatmentresistant depression, PLoS ONE, vol.8, 2013. ,
Efficacy and safety of adjunctive brexpiprazole 2 mg in major depressive disorder: a phase 3, randomized, placebo-controlled study in patients with inadequate response to antidepressants, J. Clin. Psychiatry, vol.76, pp.1224-1231, 2015. ,
Adjunctive brexpiprazole 1 and 3 mg for patients with major depressive disorder following inadequate response to antidepressants: a phase 3, randomized, double-blind study, J. Clin. Psychiatry, vol.76, pp.1232-1240, 2015. ,
Medication augmentation after the failure of SSRIs for depression, 2006. ,
, J. Med, vol.354, pp.1243-1252
The impact of childhood adversity on suicidality and clinical course in treatment-resistant depression, J. Affect. Disord, vol.152, issue.154, 2014. ,
Depression symptom dimensions as predictors of antidepressant treatment outcome: replicable evidence for interest-activity symptoms, Psychol. Med, vol.42, pp.967-980, 2012. ,
The effects of vortioxetine on cognitive dysfunction in patients with inadequate response to current antidepressants in major depressive disorder: a short-term, randomized, double-blind, exploratory study versus escitalopram, J. Affect. Disord, vol.227, pp.803-809, 2018. ,
Recovery from schizophrenia and the recovery model, Curr. Opin. Psychiatry, vol.22, pp.374-380, 2009. ,
Management of treatment-resistant depression in primary care: a mixed-methods study, Br. J. Gen. Pract, vol.68, pp.673-681, 2018. ,
Cognitive behavioural therapy as an adjunct to pharmacotherapy for primary care based patients with treatment resistant depression: results of the Cobalt randomised controlled trial, Lancet, vol.381, pp.375-384, 2013. ,
, , pp.61552-61561
Judging a book by its cover: changing "treatment resistant" to "difficult-to-treat" depression, Aust. N. Z. J. Psychiatry, vol.53, pp.101-103, 2019. ,
Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder, Bipolar Disord, vol.20, pp.97-170, 2018. ,
A systematic review and meta-analysis of deep brain stimulation in treatment-resistant depression, Prog. Neuro-Psychopharmacology Biol. Psychiatry, vol.82, pp.224-232, 2018. ,
Atypical antipsychotic augmentation for treatment-resistant depression: a systematic review and network meta-analysis, Int. J. Neuropsychopharmacol, vol.18, pp.1-10, 2015. ,
How should remission from depression be defined? The depressed patient's perspective, Am. J. Psychiatry, vol.163, pp.148-150, 2006. ,